Data from a study of device-related blood clots and the Watchman cardiac implant made by Boston Scientific (NYSE:BSX), presented today at the annual meeting of the Heart Rhythm Society in Boston, indicate the need for aggressive management of patients at risk for device-related thrombosis. There were 74 incidences of DRT in 65 of the 1,739 Watchman […]
HRS 2018
HRS 2018: Study questions benefit of ablation over drug therapy for atrial fibrillation
The annual meeting of the Heart Rhythm Society got under way in earnest today in Boston with a quintet of late-breaking clinical results from studies that sought creative ways to answer some of cardiology’s most pressing problems. “Most of these studies have not been the conventional head-to-head clinical trials with the usual bopring study structure. […]
